Real-world economic impact of onabotulinumtoxina in patients with chronic migraine

被引：0
|
作者：
Rothrock, J. F. [1 ]
Bloudek, L. M. [2 ]
Houle, T. T. [3 ]
Andress-Rothrock, D. [4 ]
Hanlon, C. [1 ]
Varon, S. F. [2 ]
机构：
[1] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA
[2] Allergan Pharmaceut Inc, Irvine, CA 92715 USA
[3] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA
[4] Univ Alabama Birmingham, Headache Treatment & Res Program, Birmingham, AL USA
来源：
JOURNAL OF HEADACHE AND PAIN | 2013年 / 14卷
关键词：
Migraine; Chronic Migraine; Episodic Migraine; onabotulinumtoxinA; Urgent Care Center;
D O I：
10.1186/1129-2377-14-S1-P216
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Real-world economic impact of onabotulinumtoxina in patients with chronic migraine
    JF Rothrock
    LM Bloudek
    TT Houle
    D Andress-Rothrock
    C Hanlon
    SF Varon
    The Journal of Headache and Pain, 2013, 14
  • [2] Real-World Economic Impact of OnabotulinumtoxinA in Patients With Chronic Migraine
    Rothrock, John F.
    Bloudek, Lisa M.
    Houle, Timothy T.
    Andress-Rothrock, Diane
    Varon, Sepideh F.
    HEADACHE, 2014, 54 (10): : 1565 - 1573
  • [3] Real-World Evidence for the Safety and Efficacy of CGRP Monoclonal Antibody Therapy Added to OnabotulinumtoxinA Treatment for Migraine Prevention in Adult Patients With Chronic Migraine
    Mechtler, Laszlo
    Saikali, Nicolas
    McVige, Jennifer
    Hughes, Olivia
    Traut, Alexandra
    Adams, Aubrey Manack
    FRONTIERS IN NEUROLOGY, 2022, 12
  • [4] A single-center retrospective study of onabotulinumtoxinA for treatment of 245 chronic migraine patients: survey results of a real-world experience
    Dikmen, Pinar Yalinay
    Kosak, Seda
    Aydinlar, Elif Ilgaz
    Kocaman, Ayse Sagduyu
    ACTA NEUROLOGICA BELGICA, 2018, 118 (03) : 475 - 484
  • [5] A single-center retrospective study of onabotulinumtoxinA for treatment of 245 chronic migraine patients: survey results of a real-world experience
    Pınar Yalinay Dikmen
    Seda Kosak
    Elif Ilgaz Aydinlar
    Ayse Sagduyu Kocaman
    Acta Neurologica Belgica, 2018, 118 : 475 - 484
  • [6] OnabotulinumtoxinA for chronic migraine during pregnancy: a real world experience on 45 patients
    Ho-Tin Wong
    Modar Khalil
    Fayyaz Ahmed
    The Journal of Headache and Pain, 2020, 21
  • [7] OnabotulinumtoxinA for chronic migraine during pregnancy: a real world experience on 45 patients
    Wong, Ho-Tin
    Khalil, Modar
    Ahmed, Fayyaz
    JOURNAL OF HEADACHE AND PAIN, 2020, 21 (01)
  • [8] Effectiveness of onabotulinumtoxinA (BOTOX®) for the preventive treatment of chronic migraine: A meta-analysis on 10 years of real-world data
    Lanteri-Minet, Michel
    Ducros, Anne
    Francois, Clement
    Olewinska, Elzbieta
    Nikodem, Mateusz
    Dupont-Benjamin, Laure
    CEPHALALGIA, 2022, 42 (14) : 1543 - 1564
  • [9] Real-world effectiveness of onabotulinumtoxinA treatment for the prevention of headaches in adults with chronic migraine in Australia: a retrospective study
    Stark, Catherine
    Stark, Richard
    Limberg, Nicole
    Rodrigues, Julian
    Cordato, Dennis
    Schwartz, Raymond
    Jukic, Robert
    JOURNAL OF HEADACHE AND PAIN, 2019, 20 (1)
  • [10] Real-world effectiveness of onabotulinumtoxinA treatment for the prevention of headaches in adults with chronic migraine in Australia: a retrospective study
    Catherine Stark
    Richard Stark
    Nicole Limberg
    Julian Rodrigues
    Dennis Cordato
    Raymond Schwartz
    Robert Jukic
    The Journal of Headache and Pain, 2019, 20
12345